MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1

Liqiang Chen, Qingli Zhu, Lingwei Lu, Yanshan Liu

Bioengineered · 2020 · 63 citations · 41 references

DOIFull text

Open access

Concepts

Abstract

. These observations indicate that miR-132 may be a suitable therapeutic target for the treatment of OSCC.

References

41